Analytical Data
-
基因名
CHSY1
- Application
-
别名
CSS1; Chondroitin sulfate synthase 1; Chondroitin glucuronyltransferase 1; Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6ZQ11
-
表达区间
Leu601~Ala800
-
分子量
56kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CHSY1, or chondroitin sulfate synthase 1, is a key enzyme involved in the biosynthesis of chondroitin sulfate, a crucial component of the extracellular matrix and a structural polysaccharide present in connective tissues. Research into CHSY1 has gained prominence due to its potential implications in various physiological and pathological processes, including cartilage development, wound healing, and tumor progression. Alterations in chondroitin sulfate levels and composition have been associated with several diseases, including osteoarthritis and cancer, highlighting the importance of CHSY1 in maintaining tissue homeostasis. Advances in recombinant protein technology have enabled the expression of CHSY1 in various systems, facilitating studies on its enzymatic activity and regulatory mechanisms. These investigations not only enhance our understanding of chondroitin sulfate biosynthesis but also offer insights into therapeutic strategies for conditions where CHSY1 function is disrupted. The development of CHSY1 recombinant proteins enables the exploration of their potential roles in modulating cell behavior and suggests avenues for biomedical applications, particularly in tissue engineering and regenerative medicine. As the understanding of CHSY1 continues to evolve, it presents promising opportunities for innovative treatments targeting diseases associated with chondroitin sulfate dysregulation.
